Preparation method of recombinant panda IL-6 immunological adjuvant
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 四川卧龙国家级自然保护区管理局
- Publication Date
- 2013-11-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates, in particular, to a preparation method of recombinant giant panda IL-6 (gpIL-6) immune adjuvant. Background technique
[0002] The giant panda is known as China's "national treasure" and is a world-class rare wild animal. However, it is on the verge of extinction. In addition to the destruction of the giant panda's habitat due to human factors, disease and death have become one of the key reasons for the current endangered giant panda population. Among the more than 40 kinds of diseases that giant pandas suffer from, canine distemper IL-6 is the most severe infectious disease that threatens the population and life safety of giant pandas. Vaccine immunization is currently the main measure to prevent and control CDV, but the vaccines currently used are not very ideal, and there are two problems of low immunization efficiency and poor safety. Therefore, improving the immunity of giant pandas under safe dose vaccination has ...